InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Caveney Brian J, Chairman & CEO. Director active across 1 companies, notably Laboratory CORP of America Holdings. Cumulatively, 9 filings have been recorded. Total volume traded: €10k. The latest transaction was filed on 7 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€9,50942.006 shares@ €226.37780.0000% mcap100.0% of flow
Common Stock
SEC:0001127602-22-017356:0·
Ideal exit: 4 Mar 2023 (T+270)
04,241 shares0
Common Stock
SEC:0001127602-22-010505:0·
284 shares
Common Stock
SEC:0001127602-22-005032:0·
560 shares
Common Stock
SEC:0001127602-22-003651:0·
560 shares
Common Stock
SEC:0001127602-22-003651·
443 shares
Common Stock
SEC:0001127602-22-003276·
443 shares
Common Stock
SEC:0001127602-22-003276:0·
2,010 shares
Common Stock
SEC:0001127602-21-028661·
2,010 shares
Common Stock
SEC:0001127602-21-028661:0·
9 of 9 declarations
About Caveney Brian J
Brian J. Caveney is Chief Executive Officer and Executive Vice President, President of the Diagnostics division at Laboratory Corp of America Holdings. He is responsible for the strategic direction of the company, focusing on innovation and improving diagnostic services.
